AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Orbis clinical drug safety9/5/2023 ![]() ![]() How to publish with us, including Open Access Journal metrics 4.2 (2022) Impact factor 4. The official representative for the Society is Dr Angela Caro Rojas, ISoP President Journal information Editor This database is shared with other Adis journals.ĭrug Safety is the official journal of the International Society of Pharmacovigilance (ISoP). Peer review is conducted using Editorial Manager®, supported by a database of international experts. Deborah Ward Clinical Recruiter Greater Chicago Area 4K followers 500+ connections Join to view profile Orbis Clinical DePaul University About I am a recruiting professional that aims to. ![]() ![]() All additional features are peer reviewed to the same high standard as the article itself. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. On September 17, 2019, FDA granted accelerated approval to pembrolizumab plus lenvatinib for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) and who have disease progression following prior systemic therapy but are not candidates for curative su. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.ĭrug Safety offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. This is achieved via the Springer Open Choice™ initiative. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.Īs a hybrid journal, Drug Safety does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. ![]()
0 Comments
Read More
Leave a Reply. |